APA (7th ed.) Citation

Valdez‑Cruz, N. A., Rosiles-Becerril, D., Martínez-Olivares, C. E., García‑Hernández, E., Cobos-Marín, L., Garzón, D., . . . Trujillo‑Roldán, M. A. (2024). Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19. Microbial Cell Factories, 23(1), 1. https://doi.org/10.1186/s12934-024-02320-5

Chicago Style (17th ed.) Citation

Valdez‑Cruz, Norma A., et al. "Oral Administration of a Recombinant Modified RBD Antigen of SARS-CoV-2 as a Possible Immunostimulant for the Care of COVID-19." Microbial Cell Factories 23, no. 1 (2024): 1. https://doi.org/10.1186/s12934-024-02320-5.

MLA (9th ed.) Citation

Valdez‑Cruz, Norma A., et al. "Oral Administration of a Recombinant Modified RBD Antigen of SARS-CoV-2 as a Possible Immunostimulant for the Care of COVID-19." Microbial Cell Factories, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12934-024-02320-5.